FDA Panel To Review Studies Of Cyberonics Device

WASHINGTON (Reuters) - A U.S. Food and Drug Administration advisory panel next month will review data on the use of Cyberonics Inc.'s VNS therapy device for depression since its approval, the agency said on Tuesday.